Navigation Links
Cardium Presents Year-End 2012 Financial Results And Recent Developments
Date:4/5/2013

etailers.  In addition, consistent with its capital-efficient business model, Cardium continues to actively evaluate new technologies and business opportunities. For more information, visit www.cardiumthx.com.

Forward-Looking Statements 

Except for statements of historical fact, the matters discussed in this press release are forward looking and reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control and may cause actual results to differ materially from expectations. For example, there is no assurance that planned product development efforts and clinical studies can be performed in an efficient and effective manner; that results or trends observed in one clinical study or procedure will be reproduced in subsequent studies or in actual use; that new clinical studies will be successful or will lead to approvals or clearances from health regulatory authorities, or that approvals in one jurisdiction will help to support studies or approvals elsewhere; that certain elements of the preferred stock financing will be approved by stockholders; that the Company will satisfy the requirements of its compliance plan and will otherwise continue to satisfy the listing requirements of its exchange or that its shares can continue to be listed on a national exchange; that we can raise sufficient capital from partnering, monetization or other fundraising transactions to maintain our stock exchange listing or adequately fund ongoing operations; that the Company can attract suitable commercialization partners for our products or that we or partners can successfully commercialize them; that our product or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive or blocked by third party proprietary rights or other means; that the products and product candidates referr
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Cardium Announces $4.0 Million Preferred Stock Financing And Reports On Exchange Listing Compliance
2. Cardium Receives ISO Certification for Excellagen
3. Cardium Announces Presentaton at The 2013 Cell & Gene Therapy Forum
4. Cardium Presents Third Quarter 2012 Financial Results and Reports on Recent Developments
5. Cardium Announces Excellagen Poster Presentatons At Desert Foot 9th Annual High Risk Diabetic Foot Conference
6. Cardium Presents Second Quarter 2012 Financial Results And Reports On Recent Developments
7. Cardium Announces Plans For Commercializaton Of Excellagen® In The Russian Federation
8. Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
9. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
10. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
11. Pharmagen Presents to North Carolina General Assembly at N.C. Bios Legislative Breakfast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 XRpro Sciences, ... drug discovery and development services which features high ... pharmaceutical industry, announced financial results for the year ... C.  Tyson, Chairman of XRpro Sciences commented, "We ... transition from development stage to commercial stage in ...
(Date:3/27/2015)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ) (TSX: ... registered offering of common shares in the ... Offering, the Company issued 7,286,432 common shares at a ... of approximately $1.45 billion. On March 18, 2015, the ... a final prospectus supplement to its effective shelf registration ...
(Date:3/27/2015)... HOLLYWOOD, Calif. , March 27, 2015 ... of life of myeloma patients while working toward prevention ... Higgins (D-NY) for introducing a federal resolution (H. ... of March 2015 as "National Multiple Myeloma Awareness Month." ... living with myeloma worldwide, and more than 110,000 new ...
Breaking Medicine Technology:XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 2Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares 3The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2
... NEW YORK , June 24 Reportlinker.com announces that a new market research ... , Global Bipolar Disorder ... http://www.reportlinker.com/p0209267/Global-Bipolar-Disorder-Industry.html , ... This report analyzes the worldwide markets for Bipolar Disorder in US$ Million. The report ...
... ALEXANDRIA, Egypt and NORCROSS, Ga. , June ... distribution company, today announced that it has signed an exclusive agreement ... Pharmaplast. , , , ... milestone agreement is the foundation for MediPurpose,s recently launched Wound Care ...
Cached Medicine Technology:Reportlinker Adds Global Bipolar Disorder Industry 2Reportlinker Adds Global Bipolar Disorder Industry 3Reportlinker Adds Global Bipolar Disorder Industry 4Reportlinker Adds Global Bipolar Disorder Industry 5Reportlinker Adds Global Bipolar Disorder Industry 6Reportlinker Adds Global Bipolar Disorder Industry 7Reportlinker Adds Global Bipolar Disorder Industry 8Reportlinker Adds Global Bipolar Disorder Industry 9Reportlinker Adds Global Bipolar Disorder Industry 10Reportlinker Adds Global Bipolar Disorder Industry 11Reportlinker Adds Global Bipolar Disorder Industry 12Reportlinker Adds Global Bipolar Disorder Industry 13Reportlinker Adds Global Bipolar Disorder Industry 14Reportlinker Adds Global Bipolar Disorder Industry 15Reportlinker Adds Global Bipolar Disorder Industry 16MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 2MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 3MediPurpose® Announces U.S. Distribution Agreement With Pharmaplast, Egyptian Advanced Wound Care OEM 4
(Date:3/27/2015)... NY (PRWEB) March 27, 2015 Ticket Down is ... Concert in 2015. After a phenomenal and highly successful ... "Nashville" will be going out on tour again in 2015 and ... tour gets underway on April 29th in New York City at ... at the Comerica Theatre on May 10th. , Fans of the ...
(Date:3/27/2015)... UK (PRWEB) March 27, 2015 DrugDev ... Melissa (Liss) Easy was named to the 2015 Philadelphia ... Under 40 list spotlights 40 dynamic, up-and-coming leaders less ... and community involvement. Winners are honored at an awards ... of the Philadelphia Business Journal. , Lyn Kremer, Publisher ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 GenSight, the ... has appointed Sean Fitzgerald, a former technology and financial ... Officer and Interim Chief Financial Officer. , Mr Fitzgerald ... technology innovator, EverFi, backed by Amazon founder and CEO ... Evan Williams. Prior to EverFi, he was a Senior ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... 27, 2015 Since September 2014, the country ... comeback tour after having been in retirement for a period ... the performer to return to touring, and concert events have ... Omaha will likely sell out for the two shows recently ... to view the inventory of discounted Garth Brooks tickets ...
Breaking Medicine News(10 mins):Health News:Nashville Live in Concert Tickets in New York, Boston, Washington, DC, Chicago, Minneapolis, San Francisco, Los Angeles and Phoenix Now On Sale at TicketDown.com 2Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:GenSight Appoints Former Technology Executive as Chief Operating Officer 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2
... Inc.,(OTC Bulletin Board: ENEI) today announced that its ... presentation at the Roth,Capital 20th Annual OC Growth ... February 21st. The conference is being held over ... Dana Point, California. The,conference will feature presentations from ...
... /PRNewswire-FirstCall/ - The Westaim Corporation,announced today that for the year ... million, or 62 cents per share, on revenues of $31.8,million ... cents per share, on,revenues of $27.6 million in the previous ... posted a net loss of $26.8 million, or 28,cents per ...
... interpersonal conflicts had more health problems, study found , , FRIDAY, ... along with others is more than a key to pleasant ... health. , Researchers who studied a survey of almost ... their relatives, friends and neighbors were less likely to report ...
... Webcast on February 21st at 12:00 p.m. Pacific Time ... (Amex: SYI ) announced today that Noah Berkowitz, ... present at,the Roth 20th Annual OC Growth Stock Conference ... (3:00 p.m. Eastern time) at the Ritz,Carlton Hotel in ...
... international study published today finds that some alternative therapies ... choices for managing most common neck pain than many ... best options for relief are exercises, education, neck mobilization, ... such as neck collars and ultrasound are not recommended. ...
... concept that chronic pain is a disease in its ... at physical, psychological, and environmental components of this major ... pain medicine expert. , Michael J Cousins AM, MD, ... Institute at the University of Sydney, Royal North Shore ...
Cached Medicine News:Health News:Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference 2Health News:Westaim announces 2007 year-end results 2Health News:Westaim announces 2007 year-end results 3Health News:Westaim announces 2007 year-end results 4Health News:Westaim announces 2007 year-end results 5Health News:Westaim announces 2007 year-end results 6Health News:Westaim announces 2007 year-end results 7Health News:Westaim announces 2007 year-end results 8Health News:Westaim announces 2007 year-end results 9Health News:Westaim announces 2007 year-end results 10Health News:Westaim announces 2007 year-end results 11Health News:Westaim announces 2007 year-end results 12Health News:Unlike Fine Wine, Crabby People Don't Age Well 2Health News:Unlike Fine Wine, Crabby People Don't Age Well 3Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 2Health News:Synvista Therapeutics to Present at the Roth 20th Annual OC Growth Stock Conference 3Health News:7-year neck pain study sheds light on best care 2Health News:7-year neck pain study sheds light on best care 3Health News:7-year neck pain study sheds light on best care 4Health News:Chronic pain should be considered a disease 2
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
The humidity chamber maintains a moist environment during immunostaining procedures as well as other laboratory procedures requiring controlled incubation steps....
Thermostatically controlled, large capacity surface to quickly evaporate water and solvents from slides and mounting media....
Liquichek Blood Gas Plus CO-Oximeter Control (IL Synthesis Series) is a combination control for use in monitoring the performance of blood gas, ion-selective electrode, biosensor and CO-Oximetry anal...
Medicine Products: